Z6尊龙官方网站

Recently, at the Beijing-Taiwan Brain Health Academic Symposium ( also known as the Beijing-Taiwan Young Scientists Forum), Zhong Yuan Bio-Technology Holdings made a significant impression and formally signed an agreement with Academician Lin Zhe'an, Chairman of the Taiwan Technology Industry Association, to jointly conduct research on Nervonic acid intervention for Parkinson's disease.

On October 13, 2023 (October 12, US EST time), Zhong Yuan through its wholly owned subsidiary Bao Feng Biotechnology (Beijing) Ltd. received patent application of publication of the granted "Nervonic Acid" function in the United States. These two patents were successfully validated in the United States through the PCT route, with a primary focus on securing patent protection for future applications of nervonic acid molecules in IVD kits and pharmaceuticals.

Recently, a team of researchers led by Dr. Xianyang Chen from Beijing Bao Feng, a prominent provider of comprehensive brain health solutions in China, collaborated with Professor Li Jiujun, Vice Dean of the Children's Hospital of China Medical University. Their groundbreaking study was published in a prestigious international journal，validated the neuroprotective effects of the Nervonic acid substances found in Bao Feng's proprietary Acer truncatum seed oil on HIE model mice.

Recently, Beijing Bao Feng, as a leading domestic provider of comprehensive brain health solutions, has made a groundbreaking discovery using lipidomics research. They have revealed the outstanding performance of Nervonic acid substances in Acer Truncatum Seed Oil in enhancing cognitive function and brain injury improvement. Additionally, they have found that Acer Truncatum Seed Oil can have potential applications as a nutritional supplement in patients with HIE (hypoxic-ischemic encephalopathy). This research achievement was published in the top global journal in the field of food science, "Food & Function," with the study conducted on the exclusive patented product of Beijing Bao Feng , the "Muzhiyuan Nervonic acid Oil" (Product Patent Certificate: ZL202010816389.2).

Bao feng Bio-technology (Beijing) Ltd, a leading provider of comprehensive brain health solutions in China, has achieved significant research breakthroughs in Nervonic acid. The research conducted by scientific team has yielded multiple achievements, including advancements in alcohol detoxification, gut microbiota metabolism, and protein disorder diagnosis, resulting in several new breakthrough products.

Bao Feng’s, a subsidiary of Zhong Yuan, R&D team together with the group of Xuanwu Hospital, Dr. Chaodong Wang, has made a breakthrough in the field of Parkinson's disease. The relevant research results of Bao Feng's biological research team have applied for invention patents and obtained intellectual property protection.